In Pictures: Inside the First Starbucks Store in Italy

One of Only Three Reserve Roasteries in the World

Source : Business Insider

Advertisements

Grilled Lamb and Fennel with Mint Almond Pesto

Ingredients

1 bulb fennel, trimmed, cored and sliced in 1/3-inch thick pieces
1 small red onion, cut in 8 wedges
1 tbsp olive oil
1 tbsp balsamic vinegar
1/2 tsp salt
1/4 tsp pepper
8 frenched lamb chops (about 600 g total)
1 tsp dried oregano

Mint Almond Pesto

1/4 cup blanched almonds, toasted
1 clove garlic, halved
1/2 cup fresh mint leaves
1/2 cup fresh parsley leaves
2 tbsp finely grated Parmesan cheese
1/4 tsp salt
pinch pepper
1/4 cup extra-virgin olive oil
1 tsp lemon juice

Method

  1. Place fennel and red onion on greased grill over medium-high heat. Close lid and grill, turning once, until softened and charred, about 10 minutes.
  2. Transfer to bowl. Toss with 1 tsp of the oil, the vinegar and half each of the salt and pepper.
  3. Rub lamb all over with remaining oil, salt, pepper and the oregano.
  4. Place on greased grill over medium-high heat. Close lid and grill, turning once, until desired doneness, about 8 minutes for medium-rare.
  5. To make the pesto, in food processor, pulse almonds with garlic until coarsely ground. Add mint, parsley, Parmesan, salt and pepper. Pulse 6 times. With motor running, add oil in thin steady stream, blending until smooth. Scrape into small bowl and stir in lemon juice.
  6. Place 2 lamb chops and some grilled vegetables on each serving plate. Top lamb chops with pesto and serve.

Makes 4 servings.

Source: Mediterranean Flavours

In Pictures: Food of Odette in Singapore

Modern French Cuisine

The Restaurant – The Best Restaurant in Singapore (#5 of Asia’s 50 Best Restaurants)

Nestlé Is Using DNA to Create Personalized Diets in Japan

Chase Purdy wrote . . . . . . .

The world’s largest food company is experimenting with people’s DNA to build and sell personalized nutrition plans that, it says, will extend lifespans and keep people healthy.

Nestlé is rolling out these new products in Japan first. Some 100,000 people are taking part in a company program there that gives consumers a kit to collect their DNA at home. The program also encourages them to use an app to post pictures of what they’re eating. Nestlé then recommends dietary changes and supplies specialized supplements that can be sprinkled on or mixed into a variety of food products, including teas, according to Bloomberg.

For years Nestlé been positioning itself to straddle the line between pharmaceuticals and food. In December 2016, then-chairman, Peter Brabeck-Letmathe made the case to Quartz that personalized, fortified foods would be the future. The dream, according to Brabeck-Letmathe, is to invent a new suite of food products that could prevent diseases from occurring. Pizzas that can ward off Alzheimer’s disease, for instance.

Brabeck-Letmathe has since retired from the company, but his vision is intact. It’s setting Nestlé apart from its food industry peers

The world’s largest food manufacturers have spent the last several years trying to regain footing with consumers in America and Europe, who lost faith in many packaged goods products because of its artificial flavors and coloring, sugar, and salt content. Nestlé, in particular, saw sales in its US frozen-foods plummet. General Mills and Kellogg’s watched as their breakfast cereals became less popular. And Coca-Cola and Pepsico both saw consumers drift away from sugary sodas, opting instead for healthier teas and flavored waters.

The shift in purchasing habits sparked companies to reformulate products to persuade consumers back into buying their foods. For Nestlé, that meant changing the ingredient lists on a whole host of well-known brand’s products, including California Pizza Kitchen, Hot Pockets, and Digiorno’s Pizza. The company sold off its US candy unit earlier this year, and recently announced a $7.15 billion licensing deal with Starbucks that will allow it to sell the Seattle-based coffee maker’s teas and coffees around the world.

Customizing meals via DNA analysis takes this recent mentality to a new level, and it’s complimenting its food efforts with investments in medical research. Since 2007, Nestlé has spent billions acquiring firms such as Novartis Medical Nutrition, Atrium Innovations, Vitaflo, Prometheus Laboratories, a minority stake in Accera, and Seres Therapeutics, Inc., to name a few.

Japan may wind up informing how Nestlé will rolls out the program in other places around the world. Until then, people will just have to wait for their personalized wonder pizzas.

Source: QUARTZ

Evidence Doesn’t Support Statin Use in Healthy Seniors

There is no evidence to support the widespread use of cholesterol-lowering statin drugs to prevent heart disease and stroke in old and very old people, Spanish researchers say.

For the new study, the investigators analyzed data from nearly 47,000 people aged 75 and older with no history of heart disease.

Statins were not associated with a reduced risk of heart disease or death from any cause in healthy people over age 75, the study found.

But among people aged 75 to 84 with type 2 diabetes, statins were linked to a 24 percent lower risk of heart disease and a 16 percent lower risk of death from any cause. This protective effect declined after age 85 and was gone by age 90, the findings showed.

The study, led by Rafel Ramos, a researcher at the University of Girona in Spain, was published online Sept. 5 in the BMJ.

The results do not support the widespread use of statins in healthy old and very old people, the study authors said. But the findings do support statin treatment in those under 85 years of age with type 2 diabetes, they concluded.

Aidan Ryan, an academic clinical fellow at University Hospital Southampton in the United Kingdom, and colleagues wrote an editorial that accompanied the study.

The editorialists noted that these observational findings need to be confirmed in randomized trials. Until then, “patient preference remains the guiding principle while we wait for better evidence,” Ryan and colleagues concluded.

Heart disease is the leading cause of death worldwide, especially among people 75 and older. Statin prescriptions to elderly patients have increased in recent decades, and clinical trial evidence supports their use in people 75 and older with existing heart disease, the study authors pointed out in a journal news release.

But there is a lack of evidence on the benefits of statins for older people without heart disease, especially those aged 85 and older, as well as those with diabetes, the researchers said.

Source: HealthDay


Today’s Comic